Predictors of Periprocedural Creatine Kinase-Myocardial Band Elevation Complicating Elective Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 99, Issue 5, 2007, Pages 616-620

  Cai, Qiangjun ^a   Skelding, Kimberly A ^a   Armstrong Jr , Arthur T ^a   Desai, Dipan ^a   Wood, G Craig ^a   Blankenship, James C ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ELECTIVE SURGERY; FEMALE; HIGH RISK PATIENT; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; SURGICAL RISK; THORAX PAIN;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; CREATINE KINASE, MB FORM; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; SURGICAL PROCEDURES, ELECTIVE;

EID: 33847011333     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.09.108     Document Type: Article

References (19)

1. Kugelmass A.D., Cohen C.J., Moscucci M., Piana R.N., Senerchia C., Kuntz R.E., and Baim D.S. Elevation of creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. Am J Cardiol 74 (1994) 748-754
2. Kong T.Q., Davidson C.J., Meyers S.N., Tauke J.T., Parker M.A., and Bonow R.O. Prognostic implications of creatine kinase elevation following elective coronary interventions. JAMA 227 (1997) 461-466
3. Ohman E.M., and Tardiff B.E. Periprocedural cardiac marker elevation after percutaneous coronary artery revascularization. JAMA 227 (1997) 495-497
4. Tardiff B.E., Califf R.M., Tcheng J.E., Lincoff A.M., Sigmon K.N., Harrington R.A., Mahaffey K.W., Ohman E.M., Teirstein P.S., Blankenship J.C., Kitt M.M., and Topol E.J. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. J Am Coll Cardiol 33 (1999) 88-96
5. Saucedo J.F., Mehran R., Dangas G., Hong M.K., Lansky A., Kent K.M., Satler L.F., Pichard A.D., Stone G.W., and Leon M.B. Long-term clinical events following creatine-kinase myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol 35 (2000) 1134-1141
6. Mehran R., Dangas G., Mintz G.S., Lansky A.J., Pichard A.D., Satler L.F., Kent K.M., Stone G.W., and Leon M.B. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions. Circulation 101 (2000) 604-610
7. Abdelmeguid A.E., Topol E.J., Whitlow P.L., Sapp S.K., and Ellis S.G. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 94 (1996) 1528-1536
8. Blankenship J.C., Islam M.A., Wood G.C., and Iliadis E.A. Angiographic adverse events during percutaneous coronary intervention fail to predict creatine kinase-MB elevation. Catheter Cardiovasc Interv 63 (2004) 31-41
9. Ellis S.G., Vandormael M.G., Cowley M.J., DiSciascio G., Deligonul U., Topol E.J., and Bulle T.M. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection. Circulation 82 (1990) 1193-1202
10. Akkerhuis K.M., Alexander J.H., Tardiff B.E., Boersma E., Harrington R.A., Lincoff A.M., and Simoons M.L. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?. Circulation 105 (2002) 554-556
11. Yen M.H., and Topol E.J. Atheromatous showers, periprocedural myocardial infarction, and fatality. Am Heart J 145 (2003) 933-935
12. Carlino M., De Gregorio J., Di Mario C., Anzuini A., Airoldi F., Albiero R., Briguori C., Dharmadhikari A., Sheiban I., and Colombo A. Prevention of distal embolization during saphenous vein graft lesion angioplasty. Experience with a new temporary occlusion and aspiration system. Circulation 99 (1999) 3221-3333
13. Iakovou I., Mintz G.S., Dangas G., Abizaid A., Mehran R., Kobayashi Y., Lansky A.J., Aymong E.D., Nikolsky E., Stone G.W., Moses J.W., and Leon M.B. Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 42 (2003) 1900-1905
14. Chung I.M., Gold H.K., Schwartz S.M., Ikari Y., Reidy M.A., and Wight T.N. Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol 40 (2002) 2072-2081
15. Chan A.W., Bhatt D.L., Chew D.P., Reginelli J., Schneider J.P., Topol E.J., and Ellis S.G. Relation of inflammation and benefit of statins after percutaneous coronary interventions. Circulation 107 (2003) 1750-1756
16. Topol E.J., and Yadav J.S. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101 (2000) 570-580
17. Blankenship J.C., Haldis T., Feit F., Hu T., Kleiman N.S., Topol E.J., Lincoff A.M., and REPLACE-2 Investigators. Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy). Am J Cardiol 97 (2006) 1591-1596
18. Smith S.C., Dove Jr. J.T., Jacobs A.K., Kennedy J.W., Kereiakes D., Kern M.J., Kuntz R.E., Popma J.J., Schaff H.V., and Williams D.O. ACC/AHA guidelines for percutaneous coronary intervention: executive summary and recommendations: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 37 (2001) 2215-2238
19. Sharma S.K., Kini A., Marmur J.D., and Fuster V. Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survival. Circulation 102 (2000) 166-172